Secondary leukemia in a child conceived using in vitro fertilization.
Kim
Young Dae
YD
Department of Pediatrics, Inje University, Seoul, Korea. kmsc29@hanmail.net
Kim
Ki Joong
KJ
Lee
Young Ho
YH
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects* / Q000627:therapeutic use; D002528:Cerebellar Neoplasms / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy* / Q000628:therapy; D017024:Chemotherapy, Adjuvant; D002675:Child, Preschool; D003520:Cyclophosphamide / Q000008:administration & dosage; D003609:Dactinomycin / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D005307:Fertilization in Vitro; D006801:Humans; D007069:Ifosfamide / Q000008:administration & dosage; D015470:Leukemia, Myeloid, Acute / Q000139:chemically induced* / Q000175:diagnosis / Q000628:therapy; D008297:Male; D016609:Neoplasms, Second Primary / Q000139:chemically induced* / Q000175:diagnosis / Q000628:therapy; D018714:Radiotherapy, Adjuvant; D012208:Rhabdomyosarcoma / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy* / Q000628:therapy; D014750:Vincristine / Q000008:administration & dosage
D003609:Dactinomycin; D014750:Vincristine; D005047:Etoposide; D003520:Cyclophosphamide; D007069:Ifosfamide